Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Avenue Mounier 73.08, B -, 1200, Brussels, Belgium.
Department of Dermatology, Melanoma Clinic, King Albert II Institute, St Luc Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Mol Imaging Biol. 2024 Jun;26(3):382-390. doi: 10.1007/s11307-023-01836-3. Epub 2023 Jun 30.
The incidence of melanoma is continuously increasing over time. Melanoma is the most aggressive skin cancer, significantly reducing quality of life and survival rates of patients at advanced stages. Therefore, early diagnosis remains the key to change the prognosis of patients with melanoma. In this context, advanced technologies are under evaluation to increase the accuracy of the diagnostic, to better characterize the lesions and visualize their possible invasiveness in the epidermis. Among the innovative methods, because melanin is paramagnetic, clinical low frequency electron paramagnetic resonance (EPR) that characterizes the melanin content in the lesion has the potential to be an adjunct diagnostic method of melanoma. In this review, we first summarize the challenges faced by dermatologists and oncologists in melanoma diagnostic and management. We also provide a historical perspective on melanin detection with a focus on EPR spectroscopy/imaging of melanomas. We describe key elements that allow EPR to move from in vitro studies to in vivo and finally to patients for melanoma studies. Finally, we provide a critical view on challenges to meet to make EPR operational in the clinic to characterize pigmented lesions.
黑色素瘤的发病率呈持续上升趋势。黑色素瘤是最具侵袭性的皮肤癌,显著降低了晚期患者的生活质量和生存率。因此,早期诊断仍然是改变黑色素瘤患者预后的关键。在这种情况下,正在评估先进技术以提高诊断的准确性,更好地描述病变特征并可视化其在表皮中的潜在侵袭性。在创新方法中,由于黑色素是顺磁性的,因此可以表征病变中黑色素含量的临床低频电子顺磁共振(EPR)有可能成为黑色素瘤的辅助诊断方法。在这篇综述中,我们首先总结了皮肤科医生和肿瘤学家在黑色素瘤诊断和管理方面面临的挑战。我们还提供了黑色素检测的历史观点,重点是黑色素瘤的 EPR 光谱/成像。我们描述了允许 EPR 从体外研究转移到体内,最终转移到患者进行黑色素瘤研究的关键要素。最后,我们对满足将 EPR 应用于临床以表征色素性病变的操作要求所面临的挑战进行了批判性的评估。